✦ LIBER ✦

Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission

✍ Scribed by Sung Ho Lee; Lool Abebe; Elisabeth Paietta; Avi Einzig; Peter H. Wiernik

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 418 KB
Volume: 84
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21431

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute lymphoblastic leukemia supervening

Acute lymphoblastic leukemia supervening in a case of chronic lymphocytic leukemia after continuous 3-year treatment with chlorambucil

✍ Dr. Sandro Eridani; Hugh Parry; Ursula Glass; Mel Greaves 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 2 views

Chemotherapy and imatinib-induced molecu

Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of “untreated” chronic myeloid leukemia

✍ Ebru Koca; Ferda Sevimli; Deniz Cetiner; Ibrahim C. Haznedaroglu; Nilgun Sayinal 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 312 KB 👁 1 views

A relapse of acute promyelocytic leukemi

A relapse of acute promyelocytic leukemia after long-term remission of 9.5 years with negative PML-RARα mRNA

✍ Inokuchi, Koiti; Tarusawa, Miki; Iwakiri, Rika; Yamaguchi, Hiroki; Dan, Kazuo 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

Predictors of response to reinduction ch

Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy

✍ Joseph M. Brandwein; Vikas Gupta; Andre C. Schuh; Aaron D. Schimmer; Karen Yee; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

## Abstract Eighty‐one patients with acute myeloid leukemia who had persistent leukemia following standard induction therapy with cytarabine plus daunorubicin (7+3 regimen) underwent reinduction therapy with a combination of mitoxantrone, etoposide, and high‐dose cytarabine (HiDAC). Patients achiev

Continuous infusion of intermediate-dose

Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: A prospective, multicenter phase II study

✍ Hawk Kim; Jae-Hoo Park; Je-Hwan Lee; Jung-Hee Lee; Young-Don Joo; Won-Sik Lee; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

The early reduction of leukemic blasts i

The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; The results of multicenter, prospective Polish adult leukemia group study

✍ Sebastian Grosicki; Jerzy Holowiecki; Sebastian Giebel; Slawomira Kyrcz-Krzemien 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views